Cenobamate-话题@MedSci

#Cenobamate#

4篇内容 | 1026人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2219067, encodeId=7d7b221906e52, content=<a href='/topic/show?id=94a85555919' target=_blank style='color:#2F92EE;'>#抗癫痫药物#</a> <a href='/topic/show?id=78b298640cb' target=_blank style='color:#2F92EE;'>#难治性癫痫#</a> <a href='/topic/show?id=eaaa448e04' target=_blank style='color:#2F92EE;'>#Cenobamate#</a> <a href='/topic/show?id=eb0511e654e2' target=_blank style='color:#2F92EE;'>#局灶性发作#</a>, objectTitle=CNS Drugs：Cenobamate作为早期辅助治疗难治性局灶性发作癫痫的观察性队列研究, objectType=article, longId=838101, objectId=417d8381015d, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240806/1722941538090_8538692.png, objectUrl=/article/show_article.do?id=417d8381015d, replyNumber=0, likeNumber=58, createdTime=2024-08-08, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=417d8381015d, moduleTitle=CNS Drugs：Cenobamate作为早期辅助治疗难治性局灶性发作癫痫的观察性队列研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=417d8381015d)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2175586, encodeId=8ead21e55864c, content=<a href='/topic/show?id=eaaa448e04' target=_blank style='color:#2F92EE;'>#Cenobamate#</a> <a href='/topic/show?id=927c108e35e7' target=_blank style='color:#2F92EE;'>#难治性局灶性癫痫#</a>, objectTitle=2023AES：多中心前瞻性观察队列中Cenobamate在难治性局灶性癫痫中的应用特点, objectType=article, longId=805300, objectId=4c348053008d, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20231215/1702632435883_2291021.jpg, objectUrl=/article/show_article.do?id=4c348053008d, replyNumber=0, likeNumber=93, createdTime=2023-12-18, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=4c348053008d, moduleTitle=2023AES：多中心前瞻性观察队列中Cenobamate在难治性局灶性癫痫中的应用特点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4c348053008d)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1968631, encodeId=5c5e196863138, content=<a href='/topic/show?id=eaaa448e04' target=_blank style='color:#2F92EE;'>#Cenobamate#</a>, objectTitle=JAMA Neurol：5种抗癫痫新药（艾司利卡西平、吡仑帕奈、布瓦西坦、大麻二酚和cenobamate）患者自杀风险评估, objectType=article, longId=217379, objectId=66d821e379ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=66d821e379ff, replyNumber=0, likeNumber=98, createdTime=2022-08-17, rootId=0, userName=zsyan, userId=dab8203, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=66d821e379ff, moduleTitle=JAMA Neurol：5种抗癫痫新药（艾司利卡西平、吡仑帕奈、布瓦西坦、大麻二酚和cenobamate）患者自杀风险评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=66d821e379ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1968630, encodeId=307d1968630f1, content=<a href='/topic/show?id=eaaa448e04' target=_blank style='color:#2F92EE;'>#Cenobamate#</a>, objectTitle=欧盟批准抗癫痫药Ontozry（cenobamate）, objectType=article, longId=209629, objectId=a3c9209629e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a3c9209629e7, replyNumber=0, likeNumber=87, createdTime=2021-10-05, rootId=0, userName=zsyan, userId=dab8203, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a3c9209629e7, moduleTitle=欧盟批准抗癫痫药Ontozry（cenobamate）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a3c9209629e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1968629, encodeId=332e19686292c, content=<a href='/topic/show?id=eaaa448e04' target=_blank style='color:#2F92EE;'>#Cenobamate#</a>, objectTitle=EMA接受抗部分性癫痫发作药物cenobamate的销售授权申请, objectType=article, longId=191490, objectId=c3f6191490db, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c3f6191490db, replyNumber=0, likeNumber=63, createdTime=2020-10-13, rootId=0, userName=zsyan, userId=dab8203, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c3f6191490db, moduleTitle=EMA接受抗部分性癫痫发作药物cenobamate的销售授权申请, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c3f6191490db)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1968628, encodeId=d1c0196862889, content=<a href='/topic/show?id=eaaa448e04' target=_blank style='color:#2F92EE;'>#Cenobamate#</a>, objectTitle=Lancet Neurol：Cenobamate治疗不受控制的局灶性癫痫, objectType=article, longId=183279, objectId=8ae81832e9cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8ae81832e9cb, replyNumber=0, likeNumber=97, createdTime=2020-04-17, rootId=0, userName=zsyan, userId=dab8203, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8ae81832e9cb, moduleTitle=Lancet Neurol：Cenobamate治疗不受控制的局灶性癫痫, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8ae81832e9cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

Cenobamate

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#抗癫痫药物# #难治性癫痫# #Cenobamate# #局灶性发作#

CNS Drugs：Cenobamate作为早期辅助治疗难治性局灶性发作癫痫的观察性队列研究

2024-08-08发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#Cenobamate# #难治性局灶性癫痫#

2023AES：多中心前瞻性观察队列中Cenobamate在难治性局灶性癫痫中的应用特点

2023-12-18发表于上海

zsyan (审核中...)

前往app查看评论内容

#Cenobamate#

JAMA Neurol：5种抗癫痫新药（艾司利卡西平、吡仑帕奈、布瓦西坦、大麻二酚和cenobamate）患者自杀风险评估

2022-08-17

zsyan (审核中...)

前往app查看评论内容

#Cenobamate#

欧盟批准抗癫痫药Ontozry（cenobamate）

2021-10-05

zsyan (审核中...)

前往app查看评论内容

#Cenobamate#

EMA接受抗部分性癫痫发作药物cenobamate的销售授权申请

2020-10-13

zsyan (审核中...)

前往app查看评论内容

#Cenobamate#

Lancet Neurol：Cenobamate治疗不受控制的局灶性癫痫

2020-04-17

科室
- - 订阅+
  - 更多科室
工具
服务